|1.||Kaiserlian, Dominique: 10 articles (05/2012 - 03/2002)|
|2.||Nicolas, Jean-François: 9 articles (01/2012 - 03/2002)|
|3.||Vocanson, Marc: 8 articles (05/2012 - 05/2005)|
|4.||Cavani, Andrea: 8 articles (06/2010 - 01/2002)|
|5.||Low, Philip S: 7 articles (09/2009 - 05/2002)|
|6.||Lu, Yingjuan: 5 articles (09/2009 - 05/2002)|
|7.||Hennino, Anca: 5 articles (07/2009 - 02/2006)|
|8.||Girolomoni, Giampiero: 5 articles (11/2008 - 01/2002)|
|9.||Chavagnac, Cyril: 5 articles (06/2007 - 10/2003)|
|10.||Saint-Mezard, Pierre: 5 articles (04/2006 - 10/2003)|
05/01/2001 - "In this study we compared the effects of subinflammatory and inflammatory doses of solar-simulated ultraviolet (UV) radiation on enhancement of skin tumor growth, sensitization to haptens and cellular changes within the epidermis of C3H/HeN mice. "
05/01/2012 - "Visualization of tumors was achieved by the delivery of mono- and divalent radiolabeled haptens. "
02/15/2006 - "UV radiation of the skin impairs immune responses to haptens and to tumor Ags. "
11/15/1994 - "The three steps were: (a) anti-hapten mAb 2D12.5 (0 h); (b) polyvalent haptenprotein conjugate chase (20 h); and (c) 88Y-labeled monovalent DOTA or bivalent Janus-DOTA haptens (21 h) and organ and tumor bioassay (24 h). "
11/01/1992 - "Janus with 50 micrograms pretargeted Mab WC3A11 resulted in significantly higher murine tumor concentrations (approximately 7%/g) compared to monovalent haptens (approximately 1.4%/g, p < 0.001), and the same high tumor-to-background ratios (approximately 3/1). "
|2.||Contact Dermatitis (Eczema, Contact)
01/01/2014 - "Contact hypersensitivity (CHS) induced by topical application of haptens is a commonly used model to study dermal inflammatory responses in mice. "
01/01/2012 - "Animal model of contact sensitivity (CS) is commonly used to study ACD in mice and can be induced by skin application of haptens. "
02/01/1995 - "These findings provide insight into the manner in which haptens are recognized by T cells involved in contact sensitivity and should facilitate the study and design of specific therapies for the manipulation of hapten-specific CD4+ T cell responses."
07/01/1994 - "Whether recognition of the haptens used to study allergic contact hypersensitivity in murine models similarly requires processing has not been determined. "
12/01/1984 - "In vivo studies with intact skin indicate that critical numbers of functioning Langerhans cells are essential for successful induction of contact hypersensitivity by epicutaneously applied haptens. "
|3.||Anaphylaxis (Anaphylactic Shock)
05/01/1982 - "Guinea-pig anaphylaxis mediated by monovalent haptens with hydrocarbon auxiliary groups: studies on the difference in elicitation between intradermally and intravenously administered hapten."
01/01/1993 - "Preventing muscle relaxant anaphylaxis with monovalent haptens. "
04/01/1968 - "Anaphylactic reactions to univalent haptens."
02/29/1928 - "1. In passively sensitized animals bacterial anaphylaxis has been produced, in vivo and in vitro, with haptens from B. "
02/29/1928 - "ON THE ROLE OF CARBOHYDRATE HAPTENS IN BACTERIAL ANAPHYLAXIS."
01/01/1980 - "Improved methods are presented for the detection of antigens and haptens by the use of the passive hemolysis inhibition test. "
01/01/1981 - "Detection of antigens and haptens by inhibition of passive immune hemolysis."
01/01/1980 - "Immunoassay of antigens and haptens by inhibition of passive immune hemolysis."
02/01/2011 - "Nanoparticles may escape the phagocytic activity of macrophages, bind to serum proteins and act as haptens; activate complement cascades; disturb the Th1/Th2 balance; cause hemolysis or thrombogenecity and may perturb the adaptive or innate immunity leading to a hyper-activated immune state or even a suppressed immunophenotype. "
|5.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
|2.||Immunoglobulin E (IgE)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Interleukin-4 (Interleukin 4)
|7.||HLA-DR Antigens (HLA-DR)
|9.||Cholecalciferol (Vitamin D3)
|10.||Morphine (MS Contin)